Medical DeviceNext-Gen ScoutingVenture Fit ScoringUnited States

Selecting Cardiac Remote Monitoring Partners for Personalised Patient Care

Which cardiac remote monitoring ventures are mature enough to support personalised patient care across our priority markets?

Strategic question

Which cardiac remote monitoring ventures are mature enough to support personalised patient care across our priority markets?

How Galen Growth helped

From market signal to decision-ready evidence

Using HealthTech Alpha and Venture Fit scoring, we evaluated 120 ventures across five priority markets against enterprise-readiness, clinical relevance and commercial maturity criteria, producing a final decision-ready shortlist of 10.

Outcomes

Cut through a crowded marketplace to isolate the small number of ventures credibly able to deliver personalised care at enterprise scale.

Decision enabled: Enabled BD and franchise teams to move decisively to partnership evaluation with a defensible top-10 list.

Key results

5Priority markets
120Ventures evaluated against criteria
10Prioritised shortlist

Our approach

A repeatable path to a defensible decision

1

Define

Clarify the strategic question, decision owner, market boundaries, and success criteria.

2

Map

Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.

3

Assess

Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.

4

Decide

Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.